ACC 2023: Late-Breaking Science Video Collection

  • Published:  06 March 2023
  • Views: 

    Views Icon

    6726

  • Likes: 

    Heart Icon

    1

Up Next

ACC 2023: Late-Breaking Science Video Collection

  • Published:  06 March 2023
  • Views: 

    Views Icon

    6726

  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
About the episode

We are joined on-site by Dr John Boehmer (Penn State Health, US) to discuss the findings of the BMAD-TX Trial, originally revealed at ACC 2023 (Zoll Medical Corporation). In this study, investigators aimed to assess the impact of a novel wearable sensor, the Microcor, (μCor™) in the management of heart failure. 266 patients with ambulatory decompensated heart failure were enrolled in the study.

The trial showed that managing heart failure using a threshold alert from the HFMS system results in 38% relative risk reduction in heart failure readmissions following hospitalisation.

Questions: 

  1. What is the importance of this study?
  2. Could you please tell us about the μCor system?
  3. What was the patient population and study design?
  4. What are the main findings?
  5. How can these findings be put into clinical practice?
  6. What further research is needed?

Recorded on site at ACC 2023, New Orleans.

Overview

Our regular review series View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provides a critical analysis of the late-breaking and featured science results and spotlights impactful data. 

 

For a deeper look into the key clinical trial data revealed at ACC 23, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviews the principal investigators in her regular Late-Breaker Discussion Series

 

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

More from this programme

Part 3

View from the Thoraxcenter

In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at ACC 2023. 

Faculty Biographies

John Boehmer

View full profile

Comments

You must be to comment. If you are not registered, you can register here.